Agreement of Tear Break-Up Time and Meniscus Height between Medmont E300 and Visionix VX120+

Please use this identifier to cite or link to this item: http://hdl.handle.net/10045/123765
Información del item - Informació de l'item - Item information
Title: Agreement of Tear Break-Up Time and Meniscus Height between Medmont E300 and Visionix VX120+
Authors: Martínez-Plaza, Elena | Molina-Martín, Ainhoa | Piñero, David P.
Research Group/s: Grupo de Óptica y Percepción Visual (GOPV)
Center, Department or Service: Universidad de Alicante. Departamento de Óptica, Farmacología y Anatomía
Keywords: Non-invasive tear break-up time | NIBUT | Tear meniscus height | TMH | Agreement | Interchangeability
Knowledge Area: Óptica
Issue Date: 30-Apr-2022
Publisher: MDPI
Citation: Martínez-Plaza E, Molina-Martín A, Piñero DP. Agreement of Tear Break-Up Time and Meniscus Height between Medmont E300 and Visionix VX120+. Applied Sciences. 2022; 12(9):4589. https://doi.org/10.3390/app12094589
Abstract: The goal of this study was to analyze the agreement between the Medmont E300 and the Visionix VX120+ systems in terms of non-invasive tear break-up time (NIBUT) and tear meniscus height (TMH) measurements. A total of 60 eyes (30 healthy subjects) were enrolled. NIBUT and TMH were evaluated with Medmont E300; first NIBUT, NIBUT50%, and TMH were evaluated with Visionix VX120+. Both evaluations were performed in a random order by the same clinician for right, left, and both eyes. The Medmont E300 provided significantly higher NIBUT than Visionix VX120+ for first NIBUT in right, left, and both eyes (p ≤ 0.003) and NIBUT50% in left and both eyes (p ≤ 0.042). The TMH measured with VX120+ was significantly higher than with Medmont E300 considering both eyes (p = 0.037). No significant correlations were found between both devices for either NIBUT (p ≥ 0.11) or TMH (p ≥ 0.09). Passing–Bablok regression analyses revealed poor agreement between devices for NIBUT and TMH outcomes. VX120+ is expected to provide substantial lower first NIBUT values than the NIBUT measured by Medmont E300. Clinicians should consider not using both instruments as interchangeable for dry eye diagnosis.
Sponsor: The author D.P.P. has been supported by the Ministry of Economy, Industry and Competitiveness of Spain within the program Ramón y Cajal, RYC-2016-20471. This research received no external funding. E.M.P. has been supported by European Union-NextGenerationEU.
URI: http://hdl.handle.net/10045/123765
ISSN: 2076-3417
DOI: 10.3390/app12094589
Language: eng
Type: info:eu-repo/semantics/article
Rights: © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Peer Review: si
Publisher version: https://doi.org/10.3390/app12094589
Appears in Collections:INV - GOPV - Artículos de Revistas

Files in This Item:
Files in This Item:
File Description SizeFormat 
ThumbnailMartinez-Plaza_etal_2022_ApplSci.pdf2,3 MBAdobe PDFOpen Preview


This item is licensed under a Creative Commons License Creative Commons